Shin Nippon Biomedical Laboratories (TSE:2395) EV-to-EBITDA : 10.10 (As of May. 21, 2024)

Shin Nippon Biomedical Laboratories EV-to-EBITDA Chart

Shin Nippon Biomedical Laboratories Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
EV-to-EBITDA		Get a 7-Day Free Trial					7.01	6.24	7.69	12.95	8.75

Shin Nippon Biomedical Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBITDA	Get a 7-Day Free Trial															12.95	13.82	15.17	11.73	-

Competitive Comparison of Shin Nippon Biomedical Laboratories's EV-to-EBITDA

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shin Nippon Biomedical Laboratories's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's EV-to-EBITDA falls into.

Shin Nippon Biomedical Laboratories EV-to-EBITDA Calculation

Shin Nippon Biomedical Laboratories's EV-to-EBITDA for today is calculated as:

Shin Nippon Biomedical Laboratories's current Enterprise Value is 円71,862 Mil.
Shin Nippon Biomedical Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円7,113 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shin Nippon Biomedical Laboratories  (TSE:2395) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Shin Nippon Biomedical Laboratories's PE Ratio for today is calculated as:

Shin Nippon Biomedical Laboratories's share price for today is 円1352.00.
Shin Nippon Biomedical Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円132.854.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Shin Nippon Biomedical Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Shin Nippon Biomedical Laboratories (TSE:2395) Business Description